Ciwon daji da Covid-19

Ciwon daji na ɗaya daga cikin cututtukan da ke haifar da ƙara haɗarin COVID-19, haɓaka zuwa rashin lafiya mai tsanani.^[1]^[2]

Hadarin rashin lafiya mai tsanani

Hukumar NHS ta Burtaniya ta yi gargadin cewa wadanda ke yin aikin chemotherapy ko radiotherapy don kansar huhu da kuma wadanda ke da sankarar kasusuwa suna da rauni ga rashin lafiya idan sun kamu da COVID-19.^[3]^[4] A Sweden, mutanen da kwanan nan suka sami chemotherapy an gano suna cikin haɗari mafi girma don haɓaka rashin lafiya mai tsanani bayan COVID-19.^[5]

Shawarwari

A Turai Society of Medical Oncology (ESMO) ya bada shawarar cewa oncologists kamata zama shirye su daidaita su asibiti routines a cikin farkawa daga cikin COVID-19 cutar AIDS . Shawarwari don amfani da sabis na telemedicine, rage yawan ziyartar asibiti, canza hanyoyin kwantar da hankali zuwa magungunan subcutaneous ko na baka, idan zai yiwu. Har ila yau ESMO ya ba da shawarar ba da shawara ga marasa lafiya game da sarrafa kamuwa da cuta.^[6]

A NHS a Ingila nanata cewa mutum haƙuri yanke shawara da za a sanya ta zantawar} ungiyoyin teams.^[3] NHS kuma ta kafa ƙungiyoyi masu fifiko ga waɗanda ke karɓar maganin cutar kansa kamar waɗanda ke da babban damar samun nasara don samun fifiko don magani akan wasu.^[3]

A Turai Society of M Oncology da shawara kan ganin marasa lafiya da ciwon daji suka kasance a kan shekaru 70 na shekaru a asibitin, sai dai shi ne na gaggawa.^[7]

Manazarta

↑ Dhodapkar M, Dhodapkar K, Ahmed R (January 2021). "Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19". Blood Cancer Discovery. 2 (1): 9–12. doi:10.1158/2643-3230.BCD-20-0177.
↑ "COVID-19 och cancer". www.internetmedicin.se. Retrieved 13 May 2020.
↑ ^3.0 ^3.1 ^3.2 Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology (in Turanci). 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319. Retrieved 13 May 2020.
↑ "Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer" (PDF). Archived from the original (PDF) on 29 July 2020. Retrieved 13 May 2020.
↑ "Förekomst och utfall av covid-19 hos personer med cancer" (PDF).
↑ "Cancer Care During the COVID-19 Pandemic: An ESMO Guide for Patients". www.esmo.org. Retrieved 13 May 2020.
↑ "ESSO Statement on COVID-19 :: ESSO". www.essoweb.org. Archived from the original on 5 November 2020. Retrieved 13 May 2020.

[1] Dhodapkar M, Dhodapkar K, Ahmed R (January 2021). "Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19". Blood Cancer Discovery. 2 (1): 9–12. doi:10.1158/2643-3230.BCD-20-0177.

[2] "COVID-19 och cancer". www.internetmedicin.se. Retrieved 13 May 2020.

[lancetoncology2-3] 3.0 ^3.1 ^3.2 Burki, Talha Khan (1 May 2020). "Cancer guidelines during the COVID-19 pandemic". The Lancet Oncology (in Turanci). 21 (5): 629–630. doi:10.1016/S1470-2045(20)30217-5. ISSN 1470-2045. PMC 7270910. PMID 32247319. Retrieved 13 May 2020.

[4] "Clinical guide for the management of noncoronavirus patients requiring acute treatment: Cancer" (PDF). Archived from the original (PDF) on 29 July 2020. Retrieved 13 May 2020.

[5] "Förekomst och utfall av covid-19 hos personer med cancer" (PDF).

[6] "Cancer Care During the COVID-19 Pandemic: An ESMO Guide for Patients". www.esmo.org. Retrieved 13 May 2020.

[7] "ESSO Statement on COVID-19 :: ESSO". www.essoweb.org. Archived from the original on 5 November 2020. Retrieved 13 May 2020.

[1]

[2]

[3]

[4]

[5]

[6]

[7]